Analyst Ratings for OncoSec Medical (ONCS) [Buys]

ONCS Rating Summary

ONCS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ONCS
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $10.67 (+217.5%) * Over Last 12-Mos
Rating Score: 8.3 / 10   Percentile Rank: 85%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/8/2021 BTIG Tom Shrader New Coverage Buy
(N/A)
10.00
(N/A)
5.23
(3.36)
-35.76% Details
7/27/2020 Dawson James Jason Kolbert New Coverage Buy
(N/A)
10.00
(N/A)
3.19
(3.36)
5.33% Details